Acasti Pharma Inc - Class A
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Acasti Pharma Inc - Class A through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Acasti Pharma Inc - Class A through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
MEI Pharma (MEIP) Presents At AACR Virtual Meeting 2021 - Slideshow via Seeking Alpha
Thermo Fisher seeks to buy pharma services company PPD for $15 billion: report via Yahoo Finance
PLx Pharma started at outperform with $20 stock price target at Oppenheimer via MarketWatch
Ledger faces class action from phishing scam victims via Cointelegraph
Acasti Pharma Inc - Class A Performance
Active Alerts for IEX:ACST
You don't have any alerts set for IEX:ACST.
About Acasti Pharma Inc - Class A
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.
Real-time ACST to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.